ZFIN ID: ZDB-FISH-150901-16813
Fish name: nr3c1s357/s357
Genotype: nr3c1s357/s357
Targeting Reagent: none
HUMAN DISEASE MODELED by nr3c1s357/s357
Human Disease Conditions Citations
generalized anxiety disorder standard conditions Sireeni et al., 2020
mental depression standard conditions Ziv et al., 2013
GENE EXPRESSION
Gene expression in nr3c1s357/s357
RNA expression
Expressed Gene Structure Conditions Figures
drd1b control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
drd2b control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
gnas control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
gnat2 control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
myb standard conditions Fig. 6 from Kwan et al., 2016
nr3c1 standard conditions Fig. S1 with image from Facchinello et al., 2017
opn1mw1 control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
pomca standard conditions Fig. 4 from Muto et al., 2013
Fig. 4 from Griffiths et al., 2012
chemical treatment: pharmaceutical Fig. 4 from Muto et al., 2013
Fig. 4 from Griffiths et al., 2012
rag2 standard conditions Fig. 6 from Kwan et al., 2016
rho standard conditions Fig. 6 from Muto et al., 2013
lighting conditions Fig. 6 from Muto et al., 2013
runx1 control Fig. 6 from Kwan et al., 2016
chemical treatment by environment: serotonin Fig. 6 from Kwan et al., 2016
th2 control Fig. 4 from Muto et al., 2013
chemical treatment: drug Fig. 4 from Muto et al., 2013
Reporter gene expression No data available
PHENOTYPE
Phenotype in nr3c1s357/s357
Phenotype Conditions Figures
camera-type eye photoreceptor cell differentiation process quality, normal lighting conditions Fig. 6 from Muto et al., 2013
camera-type eye photoreceptor cell differentiation process quality, normal standard conditions Fig. 6 from Muto et al., 2013
circadian behavior disrupted, abnormal standard conditions text only from Chiu et al., 2016
hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal standard conditions Fig. 6 from Kwan et al., 2016
hematopoietic multipotent progenitor cell decreased amount, abnormal standard conditions Fig. 6 from Kwan et al., 2016
light adaption decreased process quality, abnormal lighting conditions Fig. 1 from Muto et al., 2013
light adaption decreased process quality, abnormal standard conditions Fig. 1Fig. 2 from Muto et al., 2013
locomotory exploration behavior decreased occurrence, abnormal standard conditions Fig. 3 from Sireeni et al., 2020
optomotor response decreased process quality, abnormal lighting conditions Fig. 1 from Muto et al., 2013
optomotor response process quality, normal standard conditions Fig. 1 from Muto et al., 2013
phototransduction, visible light decreased process quality, abnormal lighting conditions Fig. 2 from Muto et al., 2013
regulation of dopamine receptor signaling pathway decreased process quality, abnormal control Fig. 4 from Muto et al., 2013
regulation of dopamine receptor signaling pathway decreased process quality, abnormal chemical treatment: drug Fig. 4 from Muto et al., 2013
retina has normal numbers of parts of type Muller cell, normal standard conditions Fig. 5 from Muto et al., 2013
retina has normal numbers of parts of type dopaminergic neuron, normal standard conditions Fig. 5 from Muto et al., 2013
sleep light phase, abnormal standard conditions text only from Chiu et al., 2016
startle response increased process quality, abnormal standard conditions Fig. 6 from Griffiths et al., 2012
swimming decreased occurrence, abnormal standard conditions Fig. 5 from Griffiths et al., 2012
swimming behavior decreased linear velocity, abnormal standard conditions Fig. 1Fig. 2Fig. 3 from Sireeni et al., 2020
thymus T cell rag2 expression decreased amount, abnormal standard conditions Fig. 6 from Kwan et al., 2016
thymus T cell decreased amount, abnormal standard conditions Fig. 6 from Kwan et al., 2016
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal chemical treatment by environment: serotonin Fig. 6 from Kwan et al., 2016
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal control Fig. 6 from Kwan et al., 2016
visual behavior decreased process quality, abnormal standard conditions Fig. 2 from Griffiths et al., 2012
whole organism increased pigmentation, abnormal standard conditions Fig. 2 from Griffiths et al., 2012
whole organism cortisol increased amount, abnormal standard conditions Fig. 4 from Facchinello et al., 2017
whole organism cortisol increased amount, abnormal mechanical stress Fig. 4 from Facchinello et al., 2017

CITATIONS  (11)